Skip to main content

Table 1 Baseline patient characteristics

From: Introducing a pharmacist-led transmural care program to reduce drug-related problems in orthogeriatric patients: a prospective interventional study

 

Control

(n = 61)

Intervention

(n = 66)

p-value

Age (years); (mean, SDa)

79 (7.7)

80 (8.4)

0.599d

Gender (male); (n,%)

18 (29.5)

16 (24.2)

0.503e

Housing before admission; (n,%)

  

0.109e

 Home

55 (90.2)

51 (77.3)

 

 Nursing home

4 (6.6)

13 (19.7)

 Serviceflat

1 (1.6)

0 (0)

 Rehabilitation facility

1 (1.6)

2 (3.0)

Recent hospitalization; (n,%)

6 (9.8)

13 (19.7)

0.120e

Type of admission; (n,%)

  

0.086e

 Urgent

24 (39.3)

36 (54.5)

 Elective

37 (60.7)

30 (45.5)

Diagnosis on admission; (n,%)

  

0.121e

 Hip and lower limb problems

54 (88.5)

49 (74.2)

 Upper limb problems

5 (8.2)

12 (18.2)

 Spinal problems

2 (3.3)

5 (7.6)

Quality of care parameters

 CCIb; (median, IQRc)

4 (2)

5 (3)

0.075f

 Fall-risk score; (median, IQR)

6 (5)

5.5 (6)

0.990f

 Patient underwent surgery; (n,%)

57 (93.4)

61 (92.4)

0.823e

Discharged to; (n,%)

  

0.108e

 Home

40 (65.6)

34 (51.5)

 Rehabilitation facility

21 (34.4)

32 (48.5)

LOS; (median, IQR)

7 (8)

11 (12)

0.013f

Number of drugs on admission per patient; (median, IQR)

6 (8)

8 (5)

0.016f

Number of drugs at discharge per patient; (median, IQR)

8 (6)

10 (6)

0.015f

Number of DRPs at discharge per patient; (median, IQR)

3 (4)

3 (4)

0.846f

Readmissions one month after discharge; (n,%)

4 (6.6)

4 (6.1)

0.908e

  1. aSD standard deviation; bCCI Charlson Comorbidity Index; cIQR Interquartile range
  2. Statistical analyses were performed using the dT-test, eChi square test, fMann-Whitney U-test